Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Comment by FerrariPalmbeacon May 24, 2017 8:48am
87 Views
Post# 26276273

RE:RE:Valeant soon to become $1 like Concordia health

RE:RE:Valeant soon to become $1 like Concordia health Deutsche Bank reiterated its $18usd price target on the drug stock -- territory not seen since late November -- saying it is "warming up" to the shares. Valeant Pharmaceuticals is now up 62% since its multi-year low of $8.31 from April 24, and VRX options traders have been buying to open calls over puts at a faster-than-usual clip. VRX stock has a 10-day call/put volume ratio of 3.30 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which ranks in the 92nd annual percentile.
<< Previous
Bullboard Posts
Next >>